AAV2.COMP-Ang1 (University of Utah)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV2.COMP-Ang1 (University of Utah)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionVascular endothelial growth factor modulatorsCadherin 5 modulators
TargetsCadherin 5Vascular endothelial growth factor
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Utah
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Utah
Active IndicationsN/A
Inactive IndicationsDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A